儿童及年轻成人甲状腺结节中的DICER1基因变异
这项回顾性队列研究纳入350例2-21岁甲状腺结节患者,采用二代测序和多重连接依赖探针扩增检测DICER1基因变异。24/350(6.9%)检出DICER1变异,DICER1阳性甲状腺乳头状癌(PTC)与滤泡亚型、包膜形成、体积较大相关,但无甲状腺外侵犯且淋巴结转移较少。作者认为DICER1阳性低危PTC可考虑更保守的管理。
要点
- 350例儿童及年轻成人甲状腺结节患者中24例(6.9%)检出DICER1基因变异。
- DICER1阳性PTC与滤泡亚型(p=0.001)、包膜形成(p=0.006)及体积较大(p=0.035)相关。
- DICER1阳性PTC无甲状腺外侵犯(p=0.039)且淋巴结转移较少(p=0.003),75%病例治疗反应极佳。
核心结论
- DICER1基因变异在儿童及年轻成人甲状腺结节中常见,本组DICER1阳性PTC侵袭性低,作者认为DICER1阳性低危PTC可考虑更保守的管理。
研究设计与样本
- 回顾性队列研究,纳入350例2-21岁甲状腺结节患者,收集275份新鲜冷冻甲状腺结节样本和92份细针穿刺活检(FNAB)样本。
- 采用二代测序和多重连接依赖探针扩增方法检测DICER1基因变异,对DICER1阳性肿瘤患者分析外周血,并将遗传分析结果与临床病理资料进行关联。
主要发现
- 24/350(6.9%;95%CI [4.4;10.0])例儿童及年轻成人患者检出DICER1基因变异。
- 良性新鲜冷冻组织患者中10/119(8.4%;95%CI [4.1;14.9])检出DICER1变异,PTC患者中8/141(5.7%;95%CI [1.9;9.5])检出,FNAB样本中6/86(7.0%;95%CI [4.1;14.6])检出。
- DICER1阳性样本中未发现其他基因改变;11/24(45.8%;95%CI [25.6;67.2])例患者检出胚系DICER1变异。
- 9/24(37.5%;95%CI [18.8;59.4])例甲状腺结节发现两个体细胞(双等位)DICER1变异,2/24(8.3%;95%CI [1.0;27.0])例发现至少3 Mbp长的体细胞缺失。
- 与DICER1阴性PTC相比,DICER1阳性PTC显著与PTC滤泡亚型(p=0.001)、包膜形成(p=0.006)相关且体积较大(p=0.035),但无甲状腺外侵犯(p=0.039)且淋巴结转移较少(p=0.003)。
关键数值与推荐
- DICER1阳性PTC患者中75%病例对治疗反应极佳。
临床怎么用
- 作者认为,对于DICER1阳性低危PTC,可考虑更保守的管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Recent studies have suggested that pathogenic variants of the DICER1 gene could be a driver of alterations in some pediatric thyroid nodules, but data are still limited. The aim of this study was to detect variants in the DICER1 gene in a large cohort of pediatric thyroid nodules and then correlate them with clinicopathological data, with a focus on the disease prognosis in patients with thyroid carcinoma. Methods: This retrospective cohort study consisted of 350 pediatric and young adult patients (aged 2-21 years) with thyroid nodules, from whom 275 fresh-frozen thyroid nodule samples and 92 fine-needle aspiration biopsy (FNAB) samples were collected. After an analysis of variants in major genetic alterations of thyroid tumors, variants in the DICER1 gene were identified using next-generation sequencing and multiplex ligation-dependent probe amplification methods. Peripheral blood was analyzed from patients with DICER1-positive tumors. The results of genetic analysis were then correlated with clinicopathological data. Results: Variants in the DICER1 gene were detected in a total of 24/350 (6.9%; 95%CI [4.4;10.0]) pediatric and young adult patients, respectively, in 10/119 (8.4%; [4.1;14.9]) patients with benign fresh-frozen tissue, in 8/141 (5.7%; [1.9;9.5]) with papillary thyroid carcinoma (PTC) and in 6/86 (7.0%; [4.1;14.6]) patients with FNAB. No other gene alteration was found in DICER1-positive samples. Germline DICER1 variants were identified in 11/24 (45.8%; [25.6;67.2]) patients. Two somatic (biallelic) variants in the DICER1 gene were found in 9/24 (37.5%; [18.8;59.4]) thyroid nodules. Somatic deletions of at least 3 Mbp long were revealed in 2/24 (8.3%; [1.0;27.0]) cases. DICER1-positive PTCs were significantly associated with the follicular subtype of PTC (p = 0.001), encapsulation (p = 0.006) and were larger in size (p = 0.035), but with no extrathyroidal extension (p = 0.039), and less frequent lymph node metastases (p = 0.003) compared with DICER1-negative PTCs. Patients with DICER1-positive PTC had an excellent response to treatment in 75% of cases. Conclusions: Variants of the DICER1 gene are frequently found in the thyroid nodules of pediatric and young adult patients. In our patients, DICER1-positive PTCs showed low invasiveness. Our findings support considering more conservative management for DICER1-positive low-risk PTCs.
引用
- Mastnikova K, Bulanova Pekova B, Kuklikova V, et al. DICER1 Variants in Pediatric and Young Adult Thyroid Nodules. Thyroid. 2024. PMID: 39283830. doi:10.1089/thy.2024.0188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。